MoonLake Immunotherapeutics (Non-dilutive financing)
Funding Details
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $500,000,000
Company Info
- Company Description
- MoonLake Immunotherapeutics is focused on advancing treatments for inflammatory diseases, including sonelokimab, which is set for 2027. The company has secured significant non-dilutive financing to support its clinical trials.
- Market
- Inflammatory diseases
- Location
- Zug, Switzerland